keyboard_arrow_up

Cervical Cancer Market Analysis and Forecast Report 2019

Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world’s fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the infection of HPV. There are no signs and symptoms to identify the early stages of cervical cancer, but it can be identified through regular check-ups. Vaginal bleeding and pelvic pain are usually observed as signs and symptoms of cervical cancer. Before cancer detected in the cervix, cervix cells go through changes, called as dysplasia, in which abnormal cells start to expose in the cervical tissue. Over a period, the abnormal cells may developed into cancer cells and begin to grow and spread more deeply into the cervix and surrounding areas.

The analysts forecast global cervical cancer market to grow at a CAGR of 4.87% over the period 2014-2019.

Covered in this Report

The report covers current scenario and the growth prospects of the global cervical cancer market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used in the treatment and prevention of cervical cancer.

The report, Global Cervical Cancer Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global cervical cancer market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Purchase a copy of the report at http://www.sandlerresearch.org/purchase?rname=43500 . (Single User License - US $2500)

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Merck

Other prominent vendors

  • Advaxis Immunotherapies
  • Bionor Pharma
  • Dendreon Corporation
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals
  • Otsuka Pharmaceuticals
  • Profectus Biosciences
  • Virometix
  • Zeria Pharmaceuticals

For more Information on the report, inquire at http://www.sandlerresearch.org/inquire-before-buying?rname=43500 .

About US:

Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.